Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced today the result ...

Hallucinations, cortical visual loss, advanced brain atrophy, and a normal CSF white blood cell count are tied to rapidly ...

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

It binds both transmembrane and soluble TREM2, triggering a rise in CSF sTREM2. Single and multi-dose studies of the small ...

Side views of the capsule during its migration at each time at non-dimensional frequency being 0.02 for capillary number being and 0.05. Credit: Journal of Fluid Mechanics (2025). DOI: 10.1017/jfm ...

Because its physical properties are so unique, understanding the fluid dynamics of flowing biological cells like these has been an important topic of research. New insights can lead to the ...

Anhui Key Laboratory of Polar Environment and Emerging Pollutants, Department of Environmental Science and Engineering, University of Science and Technology of China, Hefei 230022, China Department of ...

A single 60 mg dose of ARV-102 reduced LRRK2 protein by over 50% in cerebrospinal fluid and 90% in peripheral blood mononuclear cells. The Phase 1 trial showed ARV-102 was well tolerated ...